Floatz logo

Iloprost

Vaso-Occlusive Crises

University Hospital, RouenSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Vaso-Occlusive Crises cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Mohsen Saidinejad
Phase 2CCC
NEPENTHE
University Hospital, Tours
N/AD
Omnipaque
University Hospital, Tours
N/AD

Same molecule, other indications

Iloprost is also rated in:

systemic sclerosisDormant
BB
Indicative ·
64 / 100
View asset →
Raynaud diseaseDormant
BB
Indicative ·
64 / 100
View asset →
pulmonary fibrosisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →